New Review - Thomas et al - Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
https://t.co/yYn4jYkVHO
#LiverTwitter#NAFLD#MASLD#OncTwitter
In this Review, published in @NatRevGastroHep, the authors discuss the intersection of nonalcoholic fatty liver disease and alcohol-related liver disease, including their pathophysiology, clinical management and suggestions for future research. 🔒 https://t.co/0nfn4QpFNm
Nonnutritive sweeteners aren't inert to the human body.
Philip & @Elinav_Lab discuss the influences of nonnutritive sweeteners on glycemic responses and gut microbiome and suggest approaches to improve this situation:
https://t.co/xeyNBIBRHa
COMMENT
Research studies often use only males or do not consider sex differences. Stacey Winham & Michelle Mielke (@MayoClinic) outline recommendations for sex-specific reporting in scientific publications, providing concrete examples for doing so.
https://t.co/j6QkntzIVM
REVIEW | Led by Jae Bum Kim (Seoul Nat Univ):
The authors discuss the regulation of #lipogenesis, the physiological & pathological role of lipogenesis in adipose tissue, liver, neurons & cancer, & how lipogenesis may be targeted therapeutically.
https://t.co/pdUaTshOr2
Excited to share our recent work, where we studied the acute effect of the #CombinedMetabolicActivators administration in healthy participants and provided systematic insights into the metabolic response to the administrations. @Mardinoglu@HasanTurkez https://t.co/sNDkUFkzWb
Our Matters Arising about the critical role of serine metabolism has been published @NatMetabolism . I would like to thank everyone involved in the study. @sysmedicine@HasanTurkez
A Perspective in @NatMetabolism argues that the commonly used terms ‘mitochondrial function’ and ‘mitochondrial dysfunction’ do not do justice to the diverse mitochondrial features, activities, functions and behaviours within cells. 🔒 https://t.co/sz2IgupTQk
Our Top 25 of 2022 collections have been revealed. See which articles published last year were most popular with readers like you. #NCOMTop2Our Top 25 of 2022 collections have been revealed. See which articles published last year were most popular with readers like you. #NCOMTop2Our Top 25 of 2022 collections have been revealed. See which articles published last year were most popular with readers like you. #NCOMTop2Our Top 25 of 2022 collections have been revealed. See which articles published last year were most popular with readers like you. #NCOMTop2Our Top 25 of 2022 collections have been revealed. See which articles published last year were most popular with readers like you. #NCOMTop2Our Top 25 of 2022 collections have been revealed. See which articles published last year were most popular with readers like you. #NCOMTop25
Our new paper out! Metabolic signatures across the full spectrum of #NAFLD
https://t.co/v9ha5u0Jra
#metabolomics#lipidomics@LITMUS_IMI
Our data suggest that fibrosis F2-F3 transition marks a critical metabolic transition point in NAFLD pathogenesis.
2021 was a fantastic year for us and our collaborators.
In 2021, we published >52 papers (one per week), filed 3 patent applications and our previous publications were cited >5700 times.
Many thanks to our team members and collaborators.@SaeedShoaie@HasanTurkez@mujdatzeybel
Wonderful to see this great perspective article in @nature outlining the roadmap to create the Human Developmental Cell Atlas. With the HCA Developmental Biological Network and their collaborators worldwide.
A network-based approach reveals the dysregulated transcriptional regulation in non-alcohol fatty liver disease https://t.co/rSBucX9SFA #biorxiv_sysbio